Volume | 120,694 |
|
|||||
News | - | ||||||
Day High | 0.4975 | Low High |
|||||
Day Low | 0.4413 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
FSD Pharma Inc | HUGE | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
0.4413 | 0.4413 | 0.4975 | 0.4654 | 0.461 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
366 | 120,694 | $ 0.4732395 | $ 57,117 | - | 0.4184 - 1.78 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
19:45:25 | 7 | $ 0.4536 | USD |
FSD Pharma Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
18.1M | 38.50M | - | 0 | -23.61M | -0.61 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
FSD Pharma News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical HUGE Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.6062 | 0.6199 | 0.4184 | 0.4941369 | 121,572 | -0.1638 | -27.02% |
1 Month | 0.7051 | 0.7249 | 0.4184 | 0.6278055 | 145,074 | -0.2627 | -37.26% |
3 Months | 0.8222 | 1.09 | 0.4184 | 0.7687151 | 144,698 | -0.3798 | -46.19% |
6 Months | 1.16 | 1.50 | 0.4184 | 0.925693 | 126,025 | -0.7176 | -61.86% |
1 Year | 1.74 | 1.78 | 0.4184 | 1.14 | 133,905 | -1.30 | -74.57% |
3 Years | 1.59 | 2.25 | 0.4184 | 1.37 | 180,819 | -1.15 | -72.18% |
5 Years | 8.0497 | 14.00 | 0.4184 | 2.38 | 481,896 | -7.61 | -94.50% |
FSD Pharma Description
FSD Pharma Inc is a biopharmaceutical company developing three clinical candidates with the potential to address neuropsychiatric, neurodegenerative and inflammatory disorders. The three licensed drug candidates are LUCID-MS, a new chemical entity targeting multiple sclerosis, LUCID-PSYCH, a psychoactive molecule targeting major depressive disorder, and FSD-PEA, an ultra-micronized palmitoyl ethylamine with a favorable safety profile targeting inflammation. |